Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Obstructive Lung Diseases

  Free Subscription


Articles published in Respir Med

Retrieve available abstracts of 107 articles:
HTML format
Text format



Single Articles


    October 2018
  1. BUHL R, FitzGerald JM, Busse WW
    Tiotropium add-on to inhaled corticosteroids versus addition of long-acting beta2-agonists for adults with asthma.
    Respir Med. 2018;143:82-90.
    PubMed     Text format     Abstract available


  2. MANSUR AH, Srivastava S, Sahal A
    Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
    Respir Med. 2018;143:31-38.
    PubMed     Text format     Abstract available


  3. DAVIES SE, Bishopp A, Wharton S, Turner AM, et al
    Does Continuous Positive Airway Pressure (CPAP) treatment of obstructive sleep apnoea (OSA) improve asthma-related clinical outcomes in patients with co-existing conditions?- A systematic review.
    Respir Med. 2018;143:18-30.
    PubMed     Text format     Abstract available


  4. SCHUERMANS D, Hanon S, Wauters I, Verbanck S, et al
    Impact of a single 10 min education session on asthma control as measured by ACT.
    Respir Med. 2018;143:14-17.
    PubMed     Text format     Abstract available


  5. XIN L, Gao J, Ge X, Tian C, et al
    Increased pro-inflammatory cytokine-secreting regulatory T cells are correlated with the plasticity of T helper cell differentiation and reflect disease status in asthma.
    Respir Med. 2018;143:129-138.
    PubMed     Text format     Abstract available


  6. BIANCHI L, Bezzi M, Berlendis M, Marino S, et al
    Additive effect on pulmonary function and disability of intensive pulmonary rehabilitation following bronchoscopy lung volume reduction (BLVR) for severe emphysema.
    Respir Med. 2018;143:116-122.
    PubMed     Text format     Abstract available


  7. ALMOMANI BA, Mokhemer E, Al-Sawalha NA, Momany SM, et al
    A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma.
    Respir Med. 2018;143:103-108.
    PubMed     Text format     Abstract available


    September 2018
  8. MUNESWARAO J, Hassali MA, Verma AK
    Comment on "A novel approach of using educational pharmaceutical pictogram for improving inhaler techniques in patients with asthma".
    Respir Med. 2018 Sep 19. pii: S0954-6111(18)30294.
    PubMed     Text format    


  9. BERTI A, Volcheck GW, Cornec D, Smyth RJ, et al
    Severe/uncontrolled asthma and overall survival in atopic patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;142:66-72.
    PubMed     Text format     Abstract available


  10. HEFFLER E, Crimi C, Mancuso S, Campisi R, et al
    Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.
    Respir Med. 2018;142:48-52.
    PubMed     Text format     Abstract available


  11. CAVALLAZZI R, Jorayeva A, Beatty BL, Antimisiaris D, et al
    Predicting asthma in older adults on the basis of clinical history.
    Respir Med. 2018;142:36-40.
    PubMed     Text format     Abstract available


  12. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    30-year trends in asthma and the trends in relation to hospitalization and mortality.
    Respir Med. 2018;142:29-35.
    PubMed     Text format     Abstract available


  13. PAPAIOANNOU AI, Diamant Z, Bakakos P, Loukides S, et al
    Towards precision medicine in severe asthma: Treatment algorithms based on treatable traits.
    Respir Med. 2018;142:15-22.
    PubMed     Text format     Abstract available


    August 2018
  14. PODDIGHE D, Brambilla I, Licari A, Marseglia GL, et al
    Pediatric rhinosinusitis and asthma.
    Respir Med. 2018;141:94-99.
    PubMed     Text format     Abstract available


  15. COUMOU H, Westerhof GA, de Nijs SB, Amelink M, et al
    Diagnosing persistent blood eosinophilia in asthma with single blood eosinophil or exhaled nitric oxide level.
    Respir Med. 2018;141:81-86.
    PubMed     Text format     Abstract available


  16. BAZAN-SOCHA S, Kuczia P, Potaczek DP, Mastalerz L, et al
    Increased blood levels of cellular fibronectin in asthma: Relation to the asthma severity, inflammation, and prothrombotic blood alterations.
    Respir Med. 2018;141:64-71.
    PubMed     Text format     Abstract available


  17. ADACHI M, Kozawa M, Yoshisue H, Lee Milligan K, et al
    Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.
    Respir Med. 2018;141:56-63.
    PubMed     Text format     Abstract available


  18. SVEDSATER H, Jones R, Bosanquet N, Jacques L, et al
    Patient-reported outcomes with initiation of fluticasone furoate/vilanterol versus continuing usual care in the Asthma Salford Lung Study.
    Respir Med. 2018;141:198-206.
    PubMed     Text format     Abstract available


  19. LYCETT H, Wildman E, Raebel EM, Sherlock JP, et al
    Treatment perceptions in patients with asthma: Synthesis of factors influencing adherence.
    Respir Med. 2018;141:180-189.
    PubMed     Text format     Abstract available


  20. MCDONNELL MJ, O'Toole D, Ward C, Pearson JP, et al
    A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.
    Respir Med. 2018;141:132-143.
    PubMed     Text format     Abstract available


  21. DEVILLIER P, Humbert M, Boye A, Zachgo W, et al
    Efficacy and safety of once-daily fluticasone furoate/vilanterol (FF/VI) versus twice-daily inhaled corticosteroids/long-acting beta2-agonists (ICS/LABA) in patients with uncontrolled asthma: An open-label, randomized, controlled trial.
    Respir Med. 2018;141:111-120.
    PubMed     Text format     Abstract available


    July 2018
  22. CHEN A, Nowrouzi-Kia B, Usuba K
    Health-related quality of life in Canadians with asthma: A case-control study using census data.
    Respir Med. 2018;140:82-86.
    PubMed     Text format     Abstract available


  23. CHUNG WS, Lin CL
    Acute respiratory events in patients with bronchiectasis-COPD overlap syndrome: A population-based cohort study.
    Respir Med. 2018;140:6-10.
    PubMed     Text format     Abstract available


  24. POULSEN NN, Bjerregaard A, Khoo SK, Laing IA, et al
    Airway Interleukin-33 and type 2 cytokines in adult patients with acute asthma.
    Respir Med. 2018;140:50-56.
    PubMed     Text format     Abstract available


  25. ZHANG HP, Wang L, Wang Z, Xu XR, et al
    Chinese herbal medicine formula for acute asthma: A multi-center, randomized, double-blind, proof-of-concept trial.
    Respir Med. 2018;140:42-49.
    PubMed     Text format     Abstract available


    June 2018
  26. DE ROOS EW, Lahousse L, Verhamme KMC, Braunstahl GJ, et al
    Asthma and its comorbidities in middle-aged and older adults; the Rotterdam Study.
    Respir Med. 2018;139:6-12.
    PubMed     Text format     Abstract available


  27. MUNGAN D, Aydin O, Mahboub B, Albader M, et al
    Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: Results of the SNAPSHOT program.
    Respir Med. 2018;139:55-64.
    PubMed     Text format     Abstract available


  28. KERWIN E, Wachtel A, Sher L, Nyberg J, et al
    Efficacy, safety, and dose response of glycopyrronium administered by metered dose inhaler using co-suspension delivery technology in subjects with intermittent or mild-to-moderate persistent asthma: A randomized controlled trial.
    Respir Med. 2018;139:39-47.
    PubMed     Text format     Abstract available


  29. KARVALA K, Uitti J, Taponen S, Luukkonen R, et al
    Asthma trigger perceptions are associated with work disability.
    Respir Med. 2018;139:19-26.
    PubMed     Text format     Abstract available


  30. NAKAMOTO K, Saraya T, Ogawa Y, Ishii H, et al
    Comparison of findings on thoracic computed tomography with the severity and duration of bronchial asthma in patients with eosinophilic granulomatosis with polyangiitis.
    Respir Med. 2018;139:101-105.
    PubMed     Text format     Abstract available


    May 2018
  31. JACOB J, Odink A, Brun AL, Macaluso C, et al
    Functional associations of pleuroparenchymal fibroelastosis and emphysema with hypersensitivity pneumonitis.
    Respir Med. 2018;138:95-101.
    PubMed     Text format     Abstract available


  32. ZAFARI Z, Sadatsafavi M, Chen W, FitzGerald JM, et al
    The projected economic and health burden of sub-optimal asthma control in Canada.
    Respir Med. 2018;138:7-12.
    PubMed     Text format     Abstract available


  33. TARRAF H, Al-Jahdali H, Al Qaseer AH, Gjurovic A, et al
    Asthma control in adults in the Middle East and North Africa: Results from the ESMAA study.
    Respir Med. 2018;138:64-73.
    PubMed     Text format     Abstract available


  34. OLUWOLE O, Rennie DC, Senthilselvan A, Dyck R, et al
    The association between endotoxin and beta-(1-->3)-D-glucan in house dust with asthma severity among schoolchildren.
    Respir Med. 2018;138:38-46.
    PubMed     Text format     Abstract available


  35. BACKMAN H, Jansson SA, Stridsman C, Muellerova H, et al
    Chronic airway obstruction in a population-based adult asthma cohort: Prevalence, incidence and prognostic factors.
    Respir Med. 2018;138:115-122.
    PubMed     Text format     Abstract available


  36. KAPPELER D, Sommerer K, Kietzig C, Huber B, et al
    Pulmonary deposition of fluticasone propionate/formoterol in healthy volunteers, asthmatics and COPD patients with a novel breath-triggered inhaler.
    Respir Med. 2018;138:107-114.
    PubMed     Text format     Abstract available


    April 2018
  37. VAHATALO I, Ilmarinen P, Tuomisto LE, Niemela O, et al
    Inhaled corticosteroids and asthma control in adult-onset asthma: 12-year follow-up study.
    Respir Med. 2018;137:70-76.
    PubMed     Text format     Abstract available


  38. LIN J, Wang W, Chen P, Zhou X, et al
    Prevalence and risk factors of asthma in mainland China: The CARE study.
    Respir Med. 2018;137:48-54.
    PubMed     Text format     Abstract available


  39. SATIRER O, Mete Yesil A, Emiralioglu N, Tugcu GD, et al
    A review of the etiology and clinical presentation of non-cystic fibrosis bronchiectasis: A tertiary care experience.
    Respir Med. 2018;137:35-39.
    PubMed     Text format     Abstract available


  40. THOMSEN AML, Ehrenstein V, Riis AH, Toft G, et al
    The potential impact of paternal age on risk of asthma in childhood: a study within the Danish National Birth Cohort.
    Respir Med. 2018;137:30-34.
    PubMed     Text format     Abstract available


  41. QU Y, Zhang C, Hu Z, Li S, et al
    The 100 most influential publications in asthma from 1960 to 2017: A bibliometric analysis.
    Respir Med. 2018;137:206-212.
    PubMed     Text format     Abstract available


  42. DY T, Lewis EM, Murugan V, Gehlert S, et al
    Caregiver and pediatric provider perspectives on symptom-based inhaled corticosteroid therapy in asthma.
    Respir Med. 2018;137:201-205.
    PubMed     Text format     Abstract available


  43. WACHTEL H, Nagel M, Engel M, El Azzi G, et al
    In vitro and clinical characterization of the valved holding chamber AeroChamber Plus((R)) Flow-Vu((R)) for administrating tiotropium Respimat((R)) in 1-5-year-old children with persistent asthmatic symptoms.
    Respir Med. 2018;137:181-190.
    PubMed     Text format     Abstract available


  44. KURT OK, Ergun D, Basaran N
    Can the ceramic industry be a new and hazardous sector for work-related asthma?
    Respir Med. 2018;137:176-180.
    PubMed     Text format     Abstract available


    March 2018
  45. BRUMPTON BM, Langhammer A, Henriksen AH, Romundstad PR, et al
    Serum 25-hydroxyvitamin D, vitamin D supplement and asthma control: The HUNT study.
    Respir Med. 2018;136:65-70.
    PubMed     Text format     Abstract available


  46. CIPRANDI G, Schiavetti I, Ricciardolo FLM
    The impact of aging on outpatients with asthma in a real-world setting.
    Respir Med. 2018;136:58-64.
    PubMed     Text format     Abstract available


  47. ZELT JT, Jones JH, Hirai DM, King TJ, et al
    Systemic vascular dysfunction is associated with emphysema burden in mild COPD.
    Respir Med. 2018;136:29-36.
    PubMed     Text format     Abstract available


  48. LISSPERS K, Janson C, Larsson K, Johansson G, et al
    Comorbidity, disease burden and mortality across age groups in a Swedish primary care asthma population: An epidemiological register study (PACEHR).
    Respir Med. 2018;136:15-20.
    PubMed     Text format     Abstract available


  49. SUAREZ-CUARTIN G, Giner J, Merino JL, Rodrigo-Troyano A, et al
    Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis.
    Respir Med. 2018;136:111-117.
    PubMed     Text format     Abstract available


    February 2018
  50. GOULD CF, Perzanowski MS, Evans D, Bruzzese JM, et al
    Association of exercise-induced wheeze and other asthma symptoms with emergency department visits and hospitalizations in a large cohort of urban adolescents.
    Respir Med. 2018;135:42-50.
    PubMed     Text format     Abstract available


  51. MARTINEZ-RIVERA C, Crespo A, Pinedo-Sierra C, Garcia-Rivero JL, et al
    Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations.
    Respir Med. 2018;135:22-28.
    PubMed     Text format     Abstract available


  52. VARGAS MH, Becerril-Angeles M, Medina-Reyes IS, Rascon-Pacheco RA, et al
    Altitude above 1500m is a major determinant of asthma incidence. An ecological study.
    Respir Med. 2018;135:1-7.
    PubMed     Text format     Abstract available


    January 2018
  53. SUZUKAWA M, Matsumoto H, Ohshima N, Tashimo H, et al
    Baseline serum CXCL10 and IL-12 levels may predict severe asthmatics' responsiveness to omalizumab.
    Respir Med. 2018;134:95-102.
    PubMed     Text format     Abstract available


  54. KORENBLAT P, Kerwin E, Leshchenko I, Yen K, et al
    Efficacy and safety of lebrikizumab in adult patients with mild-to-moderate asthma not receiving inhaled corticosteroids.
    Respir Med. 2018;134:143-149.
    PubMed     Text format     Abstract available


  55. HAUGHNEY J, Morice A, Blyth KG, Lee AJ, et al
    A retrospective cohort study in severe asthma describing commonly measured biomarkers: Eosinophil count and IgE levels.
    Respir Med. 2018;134:117-123.
    PubMed     Text format     Abstract available


  56. GAO YH, Liu SX, Cui JJ, Wang LY, et al
    Subclinical atherosclerosis in adults with steady-state bronchiectasis: A case-control study.
    Respir Med. 2018;134:110-116.
    PubMed     Text format     Abstract available


    December 2017
  57. VILMANN L, Buchvald F, Green K, Nielsen KG, et al
    Fractional exhaled nitric oxide and multiple breath nitrogen washout in preschool healthy and asthmatic children.
    Respir Med. 2017;133:42-47.
    PubMed     Text format     Abstract available


  58. NICHOLSON A, Pollard SL, Lima JJ, Romero KM, et al
    Serum folate concentrations, asthma, atopy, and asthma control in Peruvian children.
    Respir Med. 2017;133:29-35.
    PubMed     Text format     Abstract available


  59. LAWSON JA, Brozek G, Shpakou A, Fedortsiv O, et al
    An international comparison of asthma, wheeze, and breathing medication use among children.
    Respir Med. 2017;133:22-28.
    PubMed     Text format     Abstract available


  60. SZENTPETERY SS, Gruzieva O, Forno E, Han YY, et al
    Combined effects of multiple risk factors on asthma in school-aged children.
    Respir Med. 2017;133:16-21.
    PubMed     Text format     Abstract available


    November 2017
  61. JUDSON MA
    Endpoints in sarcoidosis: More like IPF or asthma?
    Respir Med. 2017 Nov 20. pii: S0954-6111(17)30384.
    PubMed     Text format    


  62. SVEDSATER H, Leather D, Robinson T, Doll H, et al
    Evaluation and quantification of treatment preferences for patients with asthma or COPD using discrete choice experiment surveys.
    Respir Med. 2017;132:76-83.
    PubMed     Text format     Abstract available


  63. CONDREAY L, Chiano M, Ortega H, Buchan N, et al
    No genetic association detected with mepolizumab efficacy in severe asthma.
    Respir Med. 2017;132:178-180.
    PubMed     Text format     Abstract available


  64. SUNDH J, Wireklint P, Hasselgren M, Montgomery S, et al
    Health-related quality of life in asthma patients - A comparison of two cohorts from 2005 and 2015.
    Respir Med. 2017;132:154-160.
    PubMed     Text format     Abstract available


  65. LEE J, Kronborg C, O'Hehir RE, Hew M, et al
    Who's at risk of thunderstorm asthma? The ryegrass pollen trifecta and lessons learnt from the Melbourne thunderstorm epidemic.
    Respir Med. 2017;132:146-148.
    PubMed     Text format     Abstract available


  66. PENG YH, Su SY, Liao WC, Huang CW, et al
    Asthma is associated with endometriosis: A retrospective population-based cohort study.
    Respir Med. 2017;132:112-116.
    PubMed     Text format     Abstract available


  67. BLAIS CM, Davis BE, Cockcroft DW
    Diversity of methacholine dose-response curves among asymptomatic non-asthmatics.
    Respir Med. 2017;132:109-111.
    PubMed     Text format    


  68. MAZENQ J, Dubus JC, Gaudart J, Charpin D, et al
    City housing atmospheric pollutant impact on emergency visit for asthma: A classification and regression tree approach.
    Respir Med. 2017;132:1-8.
    PubMed     Text format     Abstract available


    October 2017
  69. BAKIRTAS A, Kutlu A, Baccioglu A, Erkekol FO, et al
    Physicians' preference for controller medication in mild persistent asthma.
    Respir Med. 2017;131:236-240.
    PubMed     Text format     Abstract available


  70. LI N, Qiu R, Yang Z, Li J, et al
    Sputum microbiota in severe asthma patients: Relationship to eosinophilic inflammation.
    Respir Med. 2017;131:192-198.
    PubMed     Text format     Abstract available


  71. SCHMIDT O, Petro W, Hoheisel G, Kanniess F, et al
    Real-life effectiveness of asthma treatment with a fixed-dose fluticasone/formoterol pressurised metered-dose inhaler - Results from a non-interventional study.
    Respir Med. 2017;131:166-174.
    PubMed     Text format     Abstract available


  72. AGGELOU K, Siafakas N
    Medical lung volume reduction for severe emphysema: A review.
    Respir Med. 2017;131:141-147.
    PubMed     Text format     Abstract available


  73. FITZGERALD JM, Tavakoli H, Lynd LD, Al Efraij K, et al
    The impact of inappropriate use of short acting beta agonists in asthma.
    Respir Med. 2017;131:135-140.
    PubMed     Text format     Abstract available


  74. ZIERAU L, Walsted ES, Thomsen SF, Backer V, et al
    Response to omalizumab in patients with severe allergic asthma: A real-life study.
    Respir Med. 2017;131:109-113.
    PubMed     Text format     Abstract available


    September 2017
  75. TALINI D, Ciberti A, Bartoli D, Del Guerra P, et al
    Work-related asthma in a sample of subjects with established asthma.
    Respir Med. 2017;130:85-91.
    PubMed     Text format     Abstract available


  76. MANISCALCO M, Zamparelli AS, Vitale DF, Faraone S, et al
    Long-term effect of weight loss induced by bariatric surgery on asthma control and health related quality of life in asthmatic patients with severe obesity: A pilot study.
    Respir Med. 2017;130:69-74.
    PubMed     Text format     Abstract available


  77. DI BONA D, Fiorino I, Taurino M, Frisenda F, et al
    Long-term "real-life" safety of omalizumab in patients with severe uncontrolled asthma: A nine-year study.
    Respir Med. 2017;130:55-60.
    PubMed     Text format     Abstract available


  78. COX CA, Boudewijn IM, Vroegop SJ, Schokker S, et al
    Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma.
    Respir Med. 2017;130:35-42.
    PubMed     Text format     Abstract available


  79. TANNO LK, Haahtela T, Calderon MA, Cruz A, et al
    Implementation gaps for asthma prevention and control.
    Respir Med. 2017;130:13-19.
    PubMed     Text format     Abstract available


    June 2017
  80. DI MARCO F, Terraneo S, Job S, Rinaldo RF, et al
    Cardiopulmonary exercise testing and second-line pulmonary function tests to detect obstructive pattern in symptomatic smokers with borderline spirometry.
    Respir Med. 2017;127:7-13.
    PubMed     Text format     Abstract available


  81. LIN J, Li J, Yu W, Liu Y, et al
    A multicenter, cross-sectional, observational study of budesonide/formoterol maintenance and reliever therapy in real-world settings.
    Respir Med. 2017;127:45-50.
    PubMed     Text format     Abstract available


  82. MACEDO P, Zhang Q, Saito J, Liang Z, et al
    Analysis of bronchial biopsies in chronic cough.
    Respir Med. 2017;127:40-44.
    PubMed     Text format     Abstract available


  83. KONNO S, Makita H, Suzuki M, Shimizu K, et al
    Acute bronchodilator responses to beta2-agonist and anticholinergic agent in COPD: Their different associations with exacerbation.
    Respir Med. 2017;127:14-20.
    PubMed     Text format     Abstract available


    May 2017
  84. GLOECKL R, Jarosch I, Bengsch U, Claus M, et al
    What's the secret behind the benefits of whole-body vibration training in patients with COPD? A randomized, controlled trial.
    Respir Med. 2017;126:17-24.
    PubMed     Text format     Abstract available


  85. MESQUITA R, Meijer K, Pitta F, Azcuna H, et al
    Changes in physical activity and sedentary behaviour following pulmonary rehabilitation in patients with COPD.
    Respir Med. 2017;126:122-129.
    PubMed     Text format     Abstract available


  86. HANANIA NA, Tashkin DP, Kerwin EM, Donohue JF, et al
    Long-term safety and efficacy of glycopyrrolate/formoterol metered dose inhaler using novel Co-Suspension Delivery Technology in patients with chronic obstructive pulmonary disease.
    Respir Med. 2017;126:105-115.
    PubMed     Text format     Abstract available


    April 2017
  87. HAYES D JR, Tumin D, Budev MM, Tobias JD, et al
    Adverse outcomes associated with pulmonary hypertension in chronic obstructive pulmonary disease after bilateral lung transplantation.
    Respir Med. 2017 Apr 22. pii: S0954-6111(17)30127.
    PubMed     Text format     Abstract available


  88. BODINI R, Santus P, Di Marco F, Aliberti S, et al
    Epidemiology of clinical trials of medicines in respiratory diseases in Europe and Italy.
    Respir Med. 2017;125:8-11.
    PubMed     Text format     Abstract available


  89. DI MARCO F, Santus P, Scichilone N, Solidoro P, et al
    Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Respir Med. 2017;125:49-56.
    PubMed     Text format     Abstract available


  90. D'URZO A, Rennard S, Kerwin E, Donohue JF, et al
    A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease.
    Respir Med. 2017;125:39-48.
    PubMed     Text format     Abstract available


  91. SHIH YN, Chen YT, Chu H, Shih CJ, et al
    Association of pre-hospital theophylline use and mortality in chronic obstructive pulmonary disease patients with sepsis.
    Respir Med. 2017;125:33-38.
    PubMed     Text format     Abstract available


  92. TOTTENBORG SS, Lange P, Thomsen RW, Nielsen H, et al
    Reducing socioeconomic inequalities in COPD care in the hospital outpatient setting - A nationwide initiative.
    Respir Med. 2017;125:19-23.
    PubMed     Text format     Abstract available


  93. HONG JY, Jung JY, Lee MG, Kim SK, et al
    Changes in the prevalence of COPD in Korea between 2001 and 2011 in the KNHANES data.
    Respir Med. 2017;125:12-18.
    PubMed     Text format     Abstract available


    March 2017
  94. ROGLIANI P, Calzetta L, Coppola A, Cavalli F, et al
    Optimizing drug delivery in COPD: The role of inhaler devices.
    Respir Med. 2017;124:6-14.
    PubMed     Text format     Abstract available


  95. KARDOS P, Vogelmeier C, Worth H, Buhl R, et al
    A two-year evaluation of the 'real life' impact of COPD on patients in Germany: The DACCORD observational study.
    Respir Med. 2017;124:57-64.
    PubMed     Text format     Abstract available


    February 2017
  96. BOURBEAU J, Aaron SD, Barnes NC, Davis KJ, et al
    Evaluating the risk of pneumonia with inhaled corticosteroids in COPD: Retrospective database studies have their limitations SA.
    Respir Med. 2017;123:94-97.
    PubMed     Text format     Abstract available


  97. PELKONEN MK, Notkola IK, Laatikainen TK, Jousilahti P, et al
    Chronic bronchitis in relation to hospitalization and mortality over three decades.
    Respir Med. 2017;123:87-93.
    PubMed     Text format     Abstract available


  98. SILER TM, Nagai A, Scott-Wilson CA, Midwinter DA, et al
    A randomised, phase III trial of once-daily fluticasone furoate/vilanterol 100/25 mug versus once-daily vilanterol 25 mug to evaluate the contribution on lung function of fluticasone furoate in the combination in patients with COPD.
    Respir Med. 2017;123:8-17.
    PubMed     Text format     Abstract available


  99. OYAMA Y, Enomoto N, Suzuki Y, Kono M, et al
    Evaluation of urinary desmosines as a noninvasive diagnostic biomarker in patients with idiopathic pleuroparenchymal fibroelastosis (PPFE).
    Respir Med. 2017;123:63-70.
    PubMed     Text format     Abstract available


  100. POMPE E, Galban CJ, Ross BD, Koenderman L, et al
    Parametric response mapping on chest computed tomography associates with clinical and functional parameters in chronic obstructive pulmonary disease.
    Respir Med. 2017;123:48-55.
    PubMed     Text format     Abstract available


  101. WANG LY, Zhu YN, Cui JJ, Yin KQ, et al
    Subclinical atherosclerosis risk markers in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis.
    Respir Med. 2017;123:18-27.
    PubMed     Text format     Abstract available


  102. MELZER AC, Ghassemieh BJ, Gillespie SE, Lindenauer PK, et al
    Patient characteristics associated with poor inhaler technique among a cohort of patients with COPD.
    Respir Med. 2017;123:124-130.
    PubMed     Text format     Abstract available


  103. DELLWEG D, Reissig K, Hoehn E, Siemon K, et al
    Inspiratory muscle training during rehabilitation in successfully weaned hypercapnic patients with COPD.
    Respir Med. 2017;123:116-123.
    PubMed     Text format     Abstract available


    January 2017
  104. BUHL R, Magder S, Bothner U, Tetzlaff K, et al
    Long-term general and cardiovascular safety of tiotropium/olodaterol in patients with moderate to very severe chronic obstructive pulmonary disease.
    Respir Med. 2017;122:58-66.
    PubMed     Text format     Abstract available


  105. LI JX, Fan LC, Li MH, Cao WJ, et al
    Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature.
    Respir Med. 2017;122:33-42.
    PubMed     Text format     Abstract available


  106. PAULIN FV, Zagatto AM, Chiappa GR, Muller PT, et al
    Addition of vitamin B12 to exercise training improves cycle ergometer endurance in advanced COPD patients: A randomized and controlled study.
    Respir Med. 2017;122:23-29.
    PubMed     Text format     Abstract available


  107. MUELLER S, Wilke T, Bechtel B, Punekar YS, et al
    Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
    Respir Med. 2017;122:1-11.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: